Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Oncoinvent (Norway)
h-index: 11
Total citations: 360
Total papers: 39
Homepage:
http://oncoinvent.com/
Recent papers from Oncoinvent (Norway)
Normal Tissue Dosimetry of Intraperitoneal ²²⁴ Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases
Journal of Nuclear Medicine · 2026
First experience with intraperitoneal 224Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer
Gynecologic Oncology · 2025
Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors
iScience · 2025
Cytotoxicity of 212Pb-labeled anti-PTK7 antibody in 2D adherent and 3D multicellular bladder cancer models
EJNMMI Radiopharmacy and Chemistry · 2025
Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy
2024
Antigen targeting and anti-tumor activity of a novel anti-CD146 212Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma
Scientific Reports · 2024
Eighteen‐Months Safety and Efficacy Following Intraperitoneal Treatment With 224 Radium‐Labeled Microparticles After CRS‐HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer
Journal of Surgical Oncology · 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance
Frontiers in Oncology · 2024
Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors
2024
Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy
Frontiers in Immunology · 2023
First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
Frontiers in Medicine · 2023
Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
Frontiers in Medicine · 2022
An Experimental Generator for Production of High-Purity²¹²Pb for Use in Radiopharmaceuticals
Journal of Nuclear Medicine · 2022
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model
Pharmaceutics · 2022
Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer
Cancers · 2021
Towards more accurate preclinical glioblastoma modelling: reverse translation of clinical standard of care in a glioblastoma mouse model
2021
Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
PLoS ONE · 2021
Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma
Cancers · 2020
Calcium Carbonate Microparticles as Carriers of 224 Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
Current Radiopharmaceuticals · 2020
Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples
Applied Radiation and Isotopes · 2020